ATLAS Project and the Future of International Collaborative Clinical Research in Asia

Abstract

National Cancer Center Japan has initiated ATLAS (Asian Clinical Trials Network for Cancers) project since 2020 with financial support from AMED that is a Japanese public funding agency. The goals of ATLAS are to strengthen multilateral cooperation with ATLAS member institutions and improve the cancer clinical research capabilities; establish robust infrastructure for conducting oncology trials with high quality clinical data; deliver novel drugs and practice changing research results to cancer patients. To achieve this goal, construction of well-organized governance as a cooperative group such as EORTC, SWOG, or JCOG is urgently needed. We have just started to prepare the establishment of the ATLAS Board that is the guardian of ATLAS’s sustainability.